PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Brain Res. Author manuscript; available in PMC 2008 December 12.
Published in final edited form as:
PMCID: PMC2170431
NIHMSID: NIHMS36062

Bidirectional ephrin/Eph Signaling in Synaptic Functions

Abstract

Eph receptors, the largest family of receptor tyrosine kinases, and their membrane bound ligands, the ephrins, are involved in multiple developmental and adult processes within and outside of the nervous system. Bi-directional signaling from both the receptor and the ligand is initiated by ephrin-Eph binding upon cell-cell contact, and involves interactions with distinct subsets of downstream signaling molecules related to specific functions. In the CNS, Ephs and ephrins act as attractive/repulsive, migratory, and cell adhesive cues during development and participate in synaptic functions in adult animals. In this review, we will focus on recent findings highlighting the functions of ephrin/Eph signaling in dendritic spine morphogenesis, synapse formation, and synaptic plasticity.

Introduction

Erythropoietin-producing hepatocellular carcinoma (Eph) receptors form the largest known family of receptor tyrosine kinases [10]. Currently, 16 genes (EphA1–10, EphB1–6) have been identified in the vertebrate genome [66] and 14 of them are present in mammals [58]. All Eph receptors are transmembrane proteins with highly conserved extra- and intracellular domains. The extracellular part of the Eph receptors includes a N-terminal ligand binding domain, a cysteine-rich region and two fibronectin type III repeats [85]. Following the juxtamembrane region is a tyrosine kinase domain, followed by a sterile-α-motif (SAM), and a type-II PSD-95/Disc large/ZO-1 (PDZ) binding motif at the carboxyl terminus [49] (Fig. 1). Eph receptors can undergo homo- as well as heterodimerization [26], which is mediated directly by the extracellular cysteine-rich region, the fibronectin type III repeats [50] and the SAM motif [73,78] or indirectly through PDZ protein interactions [25]. The Eph family receptors are divided into two groups based on the similarity of their extracellular domain sequences [10], which coincidently corresponds to their binding affinities for their respective ligands, the ephrins (Table 1).

Figure 1
Schematic drawing of the ephrin and Eph domain structures and summary of protein interactions involved in forward and reverse signaling. Discrete functional domains are labeled in red and interacting proteins are labeled in black. ↔ with solid ...
Table 1
Ephrin-Eph binding specificity and Eph receptors localization in the hippocampus

In the vertebrate genome, nine Eph Receptor Interacting Proteins (ephrin) ligands have been identified and classified based on their attachment to the cell membrane (ephrinA1–6 and ephrinB1–3). The A-ephrin ligands are bound to the membrane via a glycosylphosphoinositol (GPI) anchor while B-ephrins are type-I transmembrane proteins. Both classes of ligands contain a 20-kD receptor-binding domain, which consists of approximately 180 amino acids [60]. The cytoplasmic tail of the B-ligands is short and consists of approximately 80 amino acids. The last 33 amino acids of the ephrinB ligands display 95% sequence homology (100% conserved between ephrinB1 and B2) with a conserved type-II PDZ binding motif at the c-terminus [49,54]. Phosphorylation of several tyrosine residues in the ephrinB intracellular domain upon receptor binding enables their direct interactions with SH2/SH3 adaptor proteins, which play important roles in ephrinB reverse signaling [59,69,76] (Fig. 1).

The receptor-ligand interactions between Ephs and ephrins follow a general rule that A-ligands interact preferentially with A-receptors and B-ligands with B-receptors. The only exceptions found so far are that EphA4 and EphB2 interact with ephrinB2/3 and ephrinA5, respectively [31,35] (Table 1). Within each subfamily, the receptor-ligand interaction is believed to be rather promiscuous. High affinity heterodimers are formed between Ephs and ephrins upon cell-cell contact. The receptor-ligand heterodimers, in a 2:2 ratio, form tetramers [3638,60]. The extracellular domains on both receptors and ligands mediate tetramerization and may even enhance subfamily specificity [35,38,60]. Tetramers may then form higher order aggregates at higher concentrations [38], and may cluster into lipid raft microdomains on the cell membrane when interact with cytoplasmic PDZ proteins such as GRIP [4]. High-density clusters of Ephephrin complexes are believed to serve as signaling centers for the localization, concentration and activation of intracellular signaling molecules [3,4,58]. An interesting characteristic of Eph receptors and ephrin ligands is that they are capable of bidirectional signaling. Signaling pathways directly associated with Eph receptor activation are termed “forward” and those with ephrin activations, “reverse” signaling [41,58] (Fig. 1).

The forward and reverse signaling

Following ligand binding, Eph signaling is initiated through autophosphorylation. The activation of the kinase domain also results in the phosphorylation of the juxtamembrane domain and downstream target proteins [5,21,40,41]. One of the well studied functions of Ephs is their ability to modulate actin cytoskeletons through activation of Guanine nucleotide exchange factors (GEFs) [62]. GEFs are localized to Eph containing lipid rafts either through recruitment or constitutive binding to the phosphorylated juxtamembrane domain or the kinase domain. Each class of Eph receptors activates a unique subset of GEFs. For example, EphA receptors have been identified as interacting partners for Ephexin, Vav, and Tiam1, the RhoGEFs that are involved in axon guidance [13,44,71,77], although Tiam1 has also been implicated in NMDA receptor-mediated spine morphogenesis [79]. EphB receptors interact with a different subset of RhoGEFs (intersectin and kalirins) [46,58,67,68]. Another actin modulating protein downstream of Eph forward signaling is SHEP1 (SH2 domain-containing Eph receptor-binding protein 1), which binds Ras family GTPases (i.e. R-Ras and Rap1A) and also forms a stable complex with the scaffolding protein Crk-associated substrate (Cas) [14,20]. Through a direct interaction between the SH2-domain of SHEP1 and a conserved phospho-tyrosine motif the juxtamembrane region, activated Eph receptors can be coupled to R-Ras and Rap1A [20]. Eph receptor activation also regulates membrane ruffling and cell migration by inhibiting the interaction between SHEP1 and Cas [14]. In addition to GEFs, Eph receptors can also associate with the p120-Ras GTPase activating protein (p120-RasGAP) upon ligand binding through SH2 mediated interactions [15,23,47]. This interaction inhibits the Ras-MAPK pathway and plays important roles in growth cone collapse, cell repulsion and morphogenesis of capillary endothelium. The C-terminal PDZ-binding motif of Eph receptors mediates their interactions with many neuronal PDZ scaffolding proteins, such as glutamate receptor interacting protein (GRIP), protein interacting with C-kinase (PICK1) and AF-6 [4,39,42,81]. Forward signaling through Eph receptors induces changes to the local milieu either through modulating actin dynamics or through the localization of scaffolding molecules in lipid rafts.

Reverse signaling of the ephrin ligands is activated by Eph receptor binding. Activated ephrinB ligands are phosphorylated by Src family kinase (SFK) members (Src and Fyn) [28,65], PDGF [5], and FGF receptors [87]. Eph receptor binding leads to a rapid recruitment of SFKs to ephrinB-containing membrane microdomains and transient SFK activation [65]. Tyrosine phosphorylation of ephrins by SFKs leads to the recruitment of Grb4, a SH2 domain containing scaffolding protein that alters the actin cytoskeleton via the recruitment and activation of FAK [12]. Several mechanisms are known to regulate the tyrosine phosphorylation of ephrinBs. First, EphB receptor stimulates a metalloproteinase cleavage of ephrinB ligands, producing a C-terminal fragment that is further processed by presenilin 1/γ-secretase [28,80]. The final peptide product binds Src and inhibits its association with a negative Src regulator termed c-terminal Src kinase (Csk), allowing further activation of Src [28]. Second, after tyrosine phosphorylation, ephrinB ligands recruit a phosphotyrosine phosphotase PTP-BL through their PDZ-binding domain and are subsequently dephosphorylated [65]. In addition to PTP-BL, a number of other PDZ domain proteins (i.e. GRIP, syntenin, PSD-95, PICK1, and regulator of G-protein signaling (PDZ-RGS-3)) have been found to interact with ephrinB ligands [4,49,52,55,81]. With the exception of PTP-BL, most PDZ protein interaction with ephrinBs is constitutive and independent of the tyrosine-phosphorylation state of ephrinBs. It remains unknown what prevents PTP-BL binding to the ephrinB PDZ-binding motif prior to receptor stimulation. One possibility is that the hair-pin structure formed by the 22 residues at the N-terminal region of the last 33 residues presents a spatial obstruction for PTP-BL’s interaction with the c-terminal PDZ-binding motif, and the conformational change induced by tyrosine phosphorylation relieves this block [72]. This type of phosphorylation-dependent PDZ binding provides a switch mechanism from phosphotyrosine-dependent signaling to PDZ-domain-protein dependent signaling. So far, GRIP1/2, PDZ-RGS3, and PTP-BL are known to interact with the PDZ binding motifs of ephrinBs endogenously [4,52,65]. Beyond the signaling pathways associated with proteins directly interacting with the ephrinB c-terminus, a few novel signaling pathways have been recently discovered, perhaps through indirect interactions mediated by PDZ scaffolds. For example, ephrinB2 is found associated with metabotropic glutamate receptor 1 (mGluR1) and enhances glutamate-induced polyphosphoinositide hydrolysis [6]. EphrinB1 reverse signaling activates a novel JNK (c-Jun N-terminal Kinase) signaling pathway that results in phosphorylation-independent morphological changes in a heterologous HEK293 system [84].

Although ephrinA ligands lack an intracellular domain that could recruit scaffolding molecules, they also participate in reverse signaling by modulating cell adhesion. There is evidence suggesting that ephrinA2 or A5 activation leads to the clustering of β1-integrins in lipid microdomains through a SFK dependent mechanism [18,43]. EphrinAs are also found to interact independent of their ligand-binding domain with EphAs in cis, which prevents trans interaction and silences EphA forward signaling [8,86].

Most of Eph receptors and their cognate ephrin ligands are found expressed in the mammalian hippocampus (Tables 1 and and2).2). In this review, we will focus on the role of the ephrin/Eph family in spine morphogenesis, synapse formation, and synaptic plasticity in the hippocampus.

Table 2
Ephrin ligands localization in the hippocampus

Eph receptors and spine morphogenesis

Dendritic spines are thin, actin rich protrusions that form on the surface of dendrites. Immature spines start out as thin filopodia. Upon axo-dendritic contact, rapid cytoskeletal changes occur concurrently with the recruitment of post-synaptic density proteins [82]. This process of spine formation and retraction is highly dynamic, as a spine may change its shape by as much as 30% within a few minutes [61]. Because spine morphogenesis is usually correlated with synaptogenesis and synaptic plasticity, developmental disorders that result in abnormal synaptic transmission and serious defects in learning and memory, such as Fragile-X mental retardation, Down syndrome, Rett syndrome, and Angleman syndrome, have been attributed to defects in spine formation [16,89].

The roles of Eph receptors in spine morphogenesis have been extensively studied. In the mouse hippocampus, Eph receptors are expressed in distinct regions, as identified by in situ hybridization [32]. Immunolabeling of Eph receptors confirmed their localization in dendritic shafts, filopodial protrusions, and spine heads [45,57,68]. Henkemeyer and colleagues observed that in EphB1/B2- and EphB1/B2/B3-deficient mice, dendritic spines failed to develop [34]. F-actin rich spines were replaced by thin filopodia-shaped protrusions that lacked clustered F-actin. However, the neurons were still able to form excitatory synapses. The distribution of excitatory synapses, visualized with immunostaining of pre- and post-synaptic markers, was shifted from spines to shafts in EphB deficient mice. The increase in shaft synapse formation was accompanied by a weakening in postsynaptic PSD95 puncta size. EphB-mediated changes in excitatory synapse distribution were specific for excitatory synapse formation, as inhibitory synapses remained unperturbed. The authors propose that EphB receptors, mainly EphB1/B2, are required for and have redundant functions in spine morphogenesis.

Syndecan-2, a transmembrane heparin sulfate proteoglycan, was among the first molecules identified as major players in EphB-mediated spine formation [24]. EphB2 kinase activation upon ligand binding induces syndecan-2 clustering. Pathways downstream of syndecan-2 that ultimately leads to cytoskeletal rearrangement of the spine have yet to be elucidated. It was hypothesized that EphB2, through phosphorylation and possible direct interaction, localizes syndecan-2 to sites of nascent spines. Subsequent recruitment of syntenin and CASK by syndecan-2 via PDZ interactions may promote spinogenesis.

EphB receptors also promote spine formation through activating Rho family small GTPases. For example, two Rac1GEFs, kalirin-5 and –7, are coupled to EphB receptors and involved in regulating actin dynamics related to spine formation [67,68]. In cultured hippocampal neurons, activation of EphB forward signaling by pre-clustered ephrinB1 leads to the activation of kalirin-5 and -7 and, consequently, to an increase in dendritic spine density. In ephrinB1 treated HEK293 cells expressing both EphB2 and kalirin, EphB2 kinase activity was required for kalirin recruitment to the plasma membrane, which leads to the activation of Rac1 and its downstream effector, p21-activated protein kinase (PAK) [67]. Dominant negative forms of Rac1 and PAK inhibit EphB-mediated spine morphogenesis. Intersectin, another Rho specific for Cdc42, has also been implicated in spine formation downstream of EphB activation [46]. Intersectin is activated by ligand binding to EphB receptors. Activation of Cdc42 by intersectin promotes N-WASP-Arp2/3 complex-mediated actin polymerization. In addition, N-WASP also binds to intersectin and further upregulates its GEF activity. Linked together by intersectin, EphB and N-WASP promotes spine formation synergistically. Although some RhoGEFs are predicted to bind to EphB receptors directly, others are recruited indirectly through signaling complexes assembly upon receptor activation. For example, EphB activation leads to the assembly of a focal adhesion complex-like structure at its cytoplasmic tail, which, through a RhoGEF (possibly p190RhoGEF) activates RhoA to mediate changes to the cytoskeletal architecture. The components found in this signaling complex include FAK (focal adhesion kinase), Src, Grb2, and paxillin [56]. In the FAK knockout mouse or cultured neurons transfected with FAK-siRNA, EphB-mediated spine formation is greatly impaired. Dominant negative forms of RhoA phenocopies FAK-siRNA’s effects, while constitutively active RhoA mimics the effects of activated EphB in dendritic spine formation. Taken together, these studies demonstrate the involvement of multiple Rho family GTPases in EphB-mediated forward signaling and spine morphogenesis.

Although EphA receptors do not seem to directly promote spine formation, recent studies suggest that they may regulate spine stability. Activation of EphA4 in spines by clustered ephrinA3-Fc leads to the retraction and pruning of dendritic spines [57]. It was proposed that ephrinA3 expressed by glia cells activates EphA4 forward signaling in spine heads, possibly through the recruitment of SHEP1/Ras GTPases complexe or the RhoGEF ephexin (i.e. ephexin-5). The subsequent activation of Ras or other still unidentified Rho family GTPases achieves spine retraction and may counterbalance the pro-spinogenic effect of the EphB receptors.

Eph receptor forward signaling in synapse formation and plasticity

Eph receptors have also been studied for their roles in synapse formation. Dalva et al. [17] demonstrated that the extracellular juxtamembrane region of EphB directly interacts with the NMDA receptor subunit NR1. The EphB-NR1 interaction promotes clustering of Ca2+ permeable glutamatergic receptors at synaptic locations. EphB activation with ephrinB1-Fc clustered NMDA receptors, and unexpectedly, also led to the formation of functional presynaptic release sites, identified by FM1–43 dye labeling. The synaptogenic effect of activated EphB is dependent on the intrinsic receptor tyrosine kinase activity. Another study found that ephrinB-EphB interaction leads to the phosphorylation of key cytoplasmic residues on NR2B by Src family tyrosine kinases, which potentiates the NMDA receptor-dependent Ca2+ influx and enhances Ca-dependent gene expression [75]. The capability of postsynaptic Eph receptors to rapidly alter actin dynamics, induce synapse formation, and modulate Ca2+ influx strongly suggests a role for Ephs in mediating synaptic plasticity. In addition, Eph receptors and ephrin ligands are expressed in distinct regions of the hippocampus, and may participate in pathway-specific synaptic functions such as induction and expression of different forms of synaptic plasticity [9,31,32,48,64].

Indeed, both Eph A and B receptor families are required for synaptic plasticity. Perturbing endogenous EphA/ephrinA interaction by infusing recombinant immunoadhesins that specifically bind to the receptor binding site of the ephrin-A ligand in vivo impaired hippocampal-dependent learning [30]. Similarly, application of soluble EphA5-IgG in hippocampal slices impairs the induction of LTP [27]. Conversely, activation of endogenous EphAs by clustered ephrinA5-IgG increased synaptic transmission and improved learning [27,29]. These results indicate that the EphA/ephrinA interaction may be required for all phases of LTP at the CA3-CA1 synapse.

The functions of EphB receptors in synaptic plasticity are starting to be delineated. Impaired LTP at the Schaffer collateral-CA1 synapse and the perforant/dentate gyrus synapse, a complete absence of LTD and depotentiation at the CA1 synapse, as well as defects in hippocampus-dependent learning tasks in the EphB2 knockout mouse were reported [32,33]. Interestingly, impaired CA1 LTP, LTD and learning in the EphB2−/− mouse can be completely rescued by an EphB2LacZ knock-in allele where most of the cytoplasmic domain of EphB2 except the juxtamembrane region was replaced by β-galactosidase [32]. This suggests that EphB2 mediates synaptic plasticity in a kinase-independent manner. In CA1 pyramidal neurons, EphB2 is expressed in both pre- and post-synaptic neurons [32] (Fig. 2). It could act at the postsynaptic side by clustering NMDA receptors at the synapse [17], or at the presynaptic side by activating postsynaptic ephrinB reverse signaling, which is implicated in this form of LTP [31,70]. A regional-specific (CA1 or CA3) knock-in of EphB2LacZ in the EphB2 null mouse would directly address this issue.

Figure 2
Localization and signaling directionality of ephrins and Ephs in different regions of the mammalian hippocampus.

The involvement of EphB2 in LTP at the mossy fiber-CA3 synapse was first reported by Contractor et al. [11]. Mossy fiber LTP was completely blocked when EphB2 c-terminal peptides or antibodies directed against the EphB2 c-terminus were introduced via a recording electrode, suggesting that the c-terminus of the postsynaptic EphB2 is necessary for trans-synaptic induction of mossy fiber-CA3 LTP, which is expressed pre-synaptically. It was also shown that a postsynaptic PDZ protein, the glutamate receptor interacting protein 1 (GRIP1), is required for this trans-synaptic action, probably by enhancing EphB2 clustering through their direct interaction. Moreover, extracellular application of a blocking peptide, ephrinB1-Fc, blocked mossy fiber-CA3 LTP, while direct activation of presynaptic ephrinB reverse signaling by EphB2-Fc enhanced basal mossy fiber synaptic transmission and occluded LTP. This suggests that postsynaptic GRIP1-dependent EphB activation is necessary for presynaptic ephrinB reverse signaling, which directly mediates the presynaptic expression of this form of synaptic plasticity. The involvement of presynaptic ephrinBs in the mossy fiber LTP was also demonstrated with the ephrinB3 signaling-deficient mouse [2] (discussed below).

EphrinB ligand reverse signaling and synapse formation

Until recently, research investigating the roles of ephrinB/EphB in synaptic function has focused mainly on ephrinB-induced forward signaling through postsynaptic EphB receptors. EphrinB ligands are expressed in both pre- and post-synaptic neurons in the hippocampus [32] and are capable of reverse signaling [41]. Although ephrinB reverse signaling is not implicated in spine formation, recent evidence suggests that postsynaptic ephrinB3 may regulate synapse formation in CA1 neurons [70]. In the ephrinB3 knockout mouse, the number of excitatory CA1 synapses was increased while the size of the postsynaptic-density (PSD) was decreased, which may explain their normal basal synaptic transmission [31,70]. In the signaling-deficient ephrinB3lacZ knock-in mouse, in which the ephrinB3 cytoplasmic domain was replaced by β-galactosidase, the PSD size but not synaptic density is restored to the wild-type level [70]. Furthermore, relative to wild type animals, hippocampal synaptosomal preparations from ephrinB3 null mice showed altered levels of various synaptic proteins, most of which can be restored to normal levels in the ephrinB3lacZ knock-in mouse [70]. Although developmental compensation for the loss of synaptic function cannot be formally excluded, the observed phenotypes nonetheless provide important insights in signaling-dependent and signaling-independent functions of postsynaptic ephrinB3 in synapse formation.

Ephrin ligands and synaptic plasticity

The involvement of B-ephrin reverse signaling in synaptic plasticity has been extensively explored [2,31,70]. In agreement with the results from Contractor et al. [11], mossy fiber-CA3 LTP is completely blocked in the ephrinBLacZ mouse, the ephrinB3 signaling-deficient mutant [2], suggesting that presynaptic ephrinB3 reverse signaling is required for this pre-synaptically expressed plasticity. However, mossy fiber-CA3 LTP is normal in ephrinB3 null mutants, implying that ephrinBLacZ has a dominant negative effect and presynaptic ephrinB1 and ephrinB2, although expressed at lower levels, compensate for the loss of ephrinB3 function. Mossy fiber synapses can still be potentiated in ephrinB3LacZ mutants through forskolin-induced PKA activation. It is possible that PKA and ephrinB3 signaling are two independent pathways leading to increased presynaptic efficacy. An alternative explanation is that PKA acts downstream of presynaptic ephrinB3 signaling although the molecular mechanism connecting PKA signaling and ephrinB3 has yet to be identified.

The orientation of ephrinBs/EphBs is reversed at the CA3-CA1 synapse relative to the mossy fiber-CA3 synapse [31] (Fig. 2). Although similar genetic knockout/knock-in methods were used, the role of postsynaptic ephrins in CA1 LTP remains highly controversial [2,31,70]. Grunwald et al. [31] suggest that postsynaptic ephrinB2 and ephrinB3 are not functionally redundant in mediating CA1 LTP because ephrinB2 and ephrinB3 knockout mice exhibit similar degrees of impairment. Although multiple presynaptic Eph receptors may serve as binding partners for ephrinBs, only EphB2 and EphA4 have been studied. It was proposed that EphB2 may be required for late phase LTP [32] (but see [33]) while EphA4 serves as a presynaptic receptor for ephrinBs and functions in a signaling-independent manner in the early phase LTP [31]. By contrast, Armstrong et al. [2] did not observe any defect in the CA1 LTP in either the ephrinB3 null mouse or the ephrinB3 signaling-deficient mutant, while Rodenas-Ruano et al. [70] only observed LTP defects in the ephrinB3 null mouse but not in the signaling-deficient mouse. Mice deficient in ephrinB3 reverse signaling also performed normally in learning and memory tasks, suggesting that classical ephrinB reverse signaling is not required for mediating LTP or learning and memory. These discrepancies may be due to different lines of transgenic mice as well as varying degrees of functional compensation occurred during development. Further studies are required to reconcile the controversies and delineate the functional significance of postsynaptic ephrinBs in plasticity.

Conclusions and perspectives

Eph receptors and their ephrin ligands have long been studied for their roles in diverse aspects of development, such as tissue patterning, angiogenesis, and axon guidance [19,49,90]. The rich diversity of ephrin/Eph functions suggests that while the receptor-ligand interaction is conserved, distinct downstream signaling pathways must exist in different cell types to achieve diverse functions. In addition, the multiple combinations of receptor-ligand interactions within the large family of Eph RTKs and ephrin ligands may also serve to accomplish downstream signaling specificity.

In the nervous system, ephrin/Eph signaling mediates axon pathfinding and topographic organization of various brain regions. The roles of trans-synaptic ephrin/Eph signaling in dendritic spine morphogenesis, synapse formation, and plasticity represent exciting new additions to their known functions. The molecular mechanisms of many ephrin/Eph-related synaptic functions are still largely unknown. For example, while multiple pathways between Eph receptor activation and changes in actin dynamics have been revealed, it remains to be determined how Eph mediated spine morphogenesis is coupled to glutamatergic synapse formation, which occurs mostly on the spine structure. How does ephrinB reverse signaling contribute to synaptogenesis? What are the interactions between Eph- and ephrin- regulated synapse formation when both are present in the same neurons? Similarly, what are the interplay between ephrin/Eph and other synaptic adhesion molecules in inducing pre- and post-synaptic differentiation and maturation? In addition, both Eph receptors and ephrinB ligands are required for several forms of long-term synaptic plasticity. What are the downstream signaling mechanisms, and how do they tie in with the known classical mechanisms for LTP and LTD? Future research in synaptic ephrin/Eph signaling is expected to be exciting because understanding the fundamental mechanisms of various synaptic functions has important therapeutic implications in human mental health.

Acknowledgments

The work of the authors is supported by Mabel and Arnold Beckman Foundation, David and Lucile Packard Foundation, W. M. Keck Foundation, and NIMH.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

1. Aasheim HC, Patzke S, Hjorthaug HS, Finne EF. Characterization of a novel Eph receptor tyrosine kinase, EphA10, expressed in testis. Biochim Biophys Acta. 2005;1723:1–7. [PubMed]
2. Armstrong JN, Saganich MJ, Xu NJ, Henkemeyer M, Heinemann SF, Contractor A. B-ephrin reverse signaling is required for NMDA-independent long-term potentiation of mossy fibers in the hippocampus. J Neurosci. 2006;26:3474–3481. [PubMed]
3. Bruckner K, Klein R. Signaling by Eph receptors and their ephrin ligands. Curr Opin Neurobiol. 1998;8:375–382. [PubMed]
4. Bruckner K, Pablo Labrador J, Scheiffele P, Herb A, Seeburg PH, Klein R. EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains. Neuron. 1999;22:511–524. [PubMed]
5. Bruckner K, Pasquale EB, Klein R. Tyrosine phosphorylation of transmembrane ligands for Eph receptors. Science. 1997;275:1640–1643. [PubMed]
6. Calo L, Bruno V, Spinsanti P, Molinari G, Korkhov V, Esposito Z, Patane M, Melchiorri D, Freissmuth M, Nicoletti F. Interactions between ephrin-B and metabotropic glutamate 1 receptors in brain tissue and cultured neurons. J Neurosci. 2005;25:2245–2254. [PubMed]
7. Carpenter MK, Shilling H, VandenBos T, Beckmann MP, Cerretti DP, Kott JN, Westrum LE, Davison BL, Fletcher FA. Ligands for EPH-related tyrosine kinase receptors are developmentally regulated in the CNS. J Neurosci Res. 1995;42:199–206. [PubMed]
8. Carvalho RF, Beutler M, Marler KJ, Knoll B, Becker-Barroso E, Heintzmann R, Ng T, Drescher U. Silencing of EphA3 through a cis interaction with ephrinA5. Nat Neurosci. 2006;9:322–330. [PubMed]
9. Chen ZY, Sun C, Reuhl K, Bergemann A, Henkemeyer M, Zhou R. Abnormal hippocampal axon bundling in EphB receptor mutant mice. J Neurosci. 2004;24:2366–2374. [PubMed]
10. Eph Nomenclature Committee. Unified nomenclature for Eph family receptors and their ligands, the ephrins. Cell. 1997;90:403–404. [PubMed]
11. Contractor A, Rogers C, Maron C, Henkemeyer M, Swanson GT, Heinemann SF. Trans-synaptic Eph receptor-ephrin signaling in hippocampal mossy fiber LTP. Science. 2002;296:1864–1869. [PubMed]
12. Cowan CA, Henkemeyer M. The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals. Nature. 2001;413:174–179. [PubMed]
13. Cowan CW, Shao YR, Sahin M, Shamah SM, Lin MZ, Greer PL, Gao S, Griffith EC, Brugge JS, Greenberg ME. Vav family GEFs link activated Ephs to endocytosis and axon guidance. Neuron. 2005;46:205–217. [PubMed]
14. Dail M, Kalo MS, Seddon JA, Cote JF, Vuori K, Pasquale EB. SHEP1 function in cell migration is impaired by a single amino acid mutation that disrupts association with the scaffolding protein cas but not with Ras GTPases. J Biol Chem. 2004;279:41892–41902. [PubMed]
15. Dail M, Richter M, Godement P, Pasquale EB. Eph receptors inactivate R-Ras through different mechanisms to achieve cell repulsion. J Cell Sci. 2006;119:1244–1254. [PubMed]
16. Dailey ME, Smith SJ. The dynamics of dendritic structure in developing hippocampal slices. J Neurosci. 1996;16:2983–2994. [PubMed]
17. Dalva MB, Takasu MA, Lin MZ, Shamah SM, Hu L, Gale NW, Greenberg ME. EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell. 2000;103:945–956. [PubMed]
18. Davy A, Robbins SM. Ephrin-A5 modulates cell adhesion and morphology in an integrin-dependent manner. Embo J. 2000;19:5396–5405. [PubMed]
19. Davy A, Soriano P. Ephrin signaling in vivo: look both ways. Dev Dyn. 2005;232:1–10. [PubMed]
20. Dodelet VC, Pazzagli C, Zisch AH, Hauser CA, Pasquale EB. A novel signaling intermediate, SHEP1, directly couples Eph receptors to R-Ras and Rap1A. J Biol Chem. 1999;274:31941–31946. [PubMed]
21. Ellis C, Kasmi F, Ganju P, Walls E, Panayotou G, Reith AD. A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interaction with p59fyn. Oncogene. 1996;12:1727–1736. [PubMed]
22. Ellis J, Liu Q, Breitman M, Jenkins NA, Gilbert DJ, Copeland NG, Tempest HV, Warren S, Muir E, Schilling H, et al. Embryo brain kinase: a novel gene of the eph/elk receptor tyrosine kinase family. Mech Dev. 1995;52:319–341. [PubMed]
23. Elowe S, Holland SJ, Kulkarni S, Pawson T. Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction. Mol Cell Biol. 2001;21:7429–7441. [PMC free article] [PubMed]
24. Ethell IM, Irie F, Kalo MS, Couchman JR, Pasquale EB, Yamaguchi Y. EphB/syndecan-2 signaling in dendritic spine morphogenesis. Neuron. 2001;31:1001–1013. [PubMed]
25. Fanning AS, Anderson JM. PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. J Clin Invest. 1999;103:767–772. [PMC free article] [PubMed]
26. Freywald A, Sharfe N, Roifman CM. The kinase-null EphB6 receptor undergoes transphosphorylation in a complex with EphB1. J Biol Chem. 2002;277:3823–3828. [PubMed]
27. Gao WQ, Shinsky N, Armanini MP, Moran P, Zheng JL, Mendoza-Ramirez JL, Phillips HS, Winslow JW, Caras IW. Regulation of hippocampal synaptic plasticity by the tyrosine kinase receptor, REK7/EphA5, and its ligand, AL-1/Ephrin-A5. Mol Cell Neurosci. 1998;11:247–259. [PubMed]
28. Georgakopoulos A, Litterst C, Ghersi E, Baki L, Xu C, Serban G, Robakis NK. Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling. Embo J. 2006;25:1242–1252. [PubMed]
29. Gerlai R, McNamara A. Anesthesia induced retrograde amnesia is ameliorated by ephrinA5-IgG in mice: EphA receptor tyrosine kinases are involved in mammalian memory. Behav Brain Res. 2000;108:133–143. [PubMed]
30. Gerlai R, Shinsky N, Shih A, Williams P, Winer J, Armanini M, Cairns B, Winslow J, Gao W, Phillips HS. Regulation of learning by EphA receptors: a protein targeting study. J Neurosci. 1999;19:9538–9549. [PubMed]
31. Grunwald IC, Korte M, Adelmann G, Plueck A, Kullander K, Adams RH, Frotscher M, Bonhoeffer T, Klein R. Hippocampal plasticity requires postsynaptic ephrinBs. Nat Neurosci. 2004;7:33–40. [PubMed]
32. Grunwald IC, Korte M, Wolfer D, Wilkinson GA, Unsicker K, Lipp HP, Bonhoeffer T, Klein R. Kinase-independent requirement of EphB2 receptors in hippocampal synaptic plasticity. Neuron. 2001;32:1027–1040. [PubMed]
33. Henderson JT, Georgiou J, Jia Z, Robertson J, Elowe S, Roder JC, Pawson T. The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function. Neuron. 2001;32:1041–1056. [PubMed]
34. Henkemeyer M, Itkis OS, Ngo M, Hickmott PW, Ethell IM. Multiple EphB receptor tyrosine kinases shape dendritic spines in the hippocampus. J Cell Biol. 2003;163:1313–1326. [PMC free article] [PubMed]
35. Himanen JP, Chumley MJ, Lackmann M, Li C, Barton WA, Jeffrey PD, Vearing C, Geleick D, Feldheim DA, Boyd AW, Henkemeyer M, Nikolov DB. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nat Neurosci. 2004;7:501–509. [PubMed]
36. Himanen JP, Henkemeyer M, Nikolov DB. Crystal structure of the ligand-binding domain of the receptor tyrosine kinase EphB2. Nature. 1998;396:486–491. [PubMed]
37. Himanen JP, Nikolov DB. Purification, crystallization and preliminary characterization of an Eph-B2/ephrin-B2 complex. Acta Crystallogr D Biol Crystallogr. 2002;58:533–535. [PubMed]
38. Himanen JP, Rajashankar KR, Lackmann M, Cowan CA, Henkemeyer M, Nikolov DB. Crystal structure of an Eph receptor-ephrin complex. Nature. 2001;414:933–938. [PubMed]
39. Hock B, Bohme B, Karn T, Yamamoto T, Kaibuchi K, Holtrich U, Holland S, Pawson T, Rubsamen-Waigmann H, Strebhardt K. PDZ-domain-mediated interaction of the Eph-related receptor tyrosine kinase EphB3 and the ras-binding protein AF6 depends on the kinase activity of the receptor. Proc Natl Acad Sci U S A. 1998;95:9779–9784. [PubMed]
40. Holland SJ, Gale NW, Gish GD, Roth RA, Songyang Z, Cantley LC, Henkemeyer M, Yancopoulos GD, Pawson T. Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells. Embo J. 1997;16:3877–3888. [PubMed]
41. Holland SJ, Gale NW, Mbamalu G, Yancopoulos GD, Henkemeyer M, Pawson T. Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. Nature. 1996;383:722–725. [PubMed]
42. Hoogenraad CC, Milstein AD, Ethell IM, Henkemeyer M, Sheng M. GRIP1 controls dendrite morphogenesis by regulating EphB receptor trafficking. Nat Neurosci. 2005;8:906–915. [PubMed]
43. Huai J, Drescher U. An ephrin-A-dependent signaling pathway controls integrin function and is linked to the tyrosine phosphorylation of a 120-kDa protein. J Biol Chem. 2001;276:6689–6694. [PubMed]
44. Hunter SG, Zhuang G, Brantley-Sieders D, Swat W, Cowan CW, Chen J. Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis. Mol Cell Biol. 2006;26:4830–4842. [PMC free article] [PubMed]
45. Irie F, Yamaguchi Y. EPHB receptor signaling in dendritic spine development. Front Biosci. 2004;9:1365–1373. [PubMed]
46. Irie F, Yamaguchi Y. EphB receptors regulate dendritic spine development via intersectin, Cdc42 and N-WASP. Nat Neurosci. 2002;5:1117–1118. [PubMed]
47. Kim I, Ryu YS, Kwak HJ, Ahn SY, Oh JL, Yancopoulos GD, Gale NW, Koh GY. EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells. Faseb J. 2002;16:1126–1128. [PubMed]
48. Klein R. Eph/ephrin signaling in morphogenesis, neural development and plasticity. Curr Opin Cell Biol. 2004;16:580–589. [PubMed]
49. Kullander K, Klein R. Mechanisms and functions of Eph and ephrin signalling. Nat Rev Mol Cell Biol. 2002;3:475–486. [PubMed]
50. Lackmann M, Oates AC, Dottori M, Smith FM, Do C, Power M, Kravets L, Boyd AW. Distinct subdomains of the EphA3 receptor mediate ligand binding and receptor dimerization. J Biol Chem. 1998;273:20228–20237. [PubMed]
51. Liebl DJ, Morris CJ, Henkemeyer M, Parada LF. mRNA expression of ephrins and Eph receptor tyrosine kinases in the neonatal and adult mouse central nervous system. J Neurosci Res. 2003;71:7–22. [PubMed]
52. Lu Q, Sun EE, Klein RS, Flanagan JG. Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell. 2001;105:69–79. [PubMed]
53. Maisonpierre PC, Barrezueta NX, Yancopoulos GD. Ehk-1 and Ehk-2: two novel members of the Eph receptor-like tyrosine kinase family with distinctive structures and neuronal expression. Oncogene. 1993;8:3277–3288. [PubMed]
54. Martinez A, Soriano E. Functions of ephrin/Eph interactions in the development of the nervous system: emphasis on the hippocampal system. Brain Res Brain Res Rev. 2005;49:211–226. [PubMed]
55. Meyer G, Varoqueaux F, Neeb A, Oschlies M, Brose N. The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin. Neuropharmacology. 2004;47:724–733. [PubMed]
56. Moeller ML, Shi Y, Reichardt LF, Ethell IM. EphB receptors regulate dendritic spine morphogenesis through the recruitment/phosphorylation of focal adhesion kinase and RhoA activation. J Biol Chem. 2006;281:1587–1598. [PubMed]
57. Murai KK, Nguyen LN, Irie F, Yamaguchi Y, Pasquale EB. Control of hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling. Nat Neurosci. 2003;6:153–160. [PubMed]
58. Murai KK, Pasquale EB. ‘Eph’ective signaling: forward, reverse and crosstalk. J Cell Sci. 2003;116:2823–2832. [PubMed]
59. Nakada M, Drake KL, Nakada S, Niska JA, Berens ME. Ephrin-B3 Ligand Promotes Glioma Invasion through Activation of Rac1. Cancer Res. 2006;66:8492–8500. [PubMed]
60. Nikolov DB, Li C, Barton WA, Himanen JP. Crystal structure of the ephrin-B1 ectodomain: implications for receptor recognition and signaling. Biochemistry. 2005;44:10947–10953. [PubMed]
61. Nimchinsky EA, Sabatini BL, Svoboda K. Structure and function of dendritic spines. Annu Rev Physiol. 2002;64:313–353. [PubMed]
62. Noren NK, Pasquale EB. Eph receptor-ephrin bidirectional signals that target Ras and Rho proteins. Cell Signal. 2004;16:655–666. [PubMed]
63. Otal R, Burgaya F, Frisen J, Soriano E, Martinez A. Ephrin-A5 modulates the topographic mapping and connectivity of commissural axons in murine hippocampus. Neuroscience. 2006;141:109–121. [PubMed]
64. Palmer A, Klein R. Multiple roles of ephrins in morphogenesis, neuronal networking, and brain function. Genes Dev. 2003;17:1429–1450. [PubMed]
65. Palmer A, Zimmer M, Erdmann KS, Eulenburg V, Porthin A, Heumann R, Deutsch U, Klein R. EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. Mol Cell. 2002;9:725–737. [PubMed]
66. Pasquale EB. Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol. 2005;6:462–475. [PubMed]
67. Penzes P, Beeser A, Chernoff J, Schiller MR, Eipper BA, Mains RE, Huganir RL. Rapid induction of dendritic spine morphogenesis by trans-synaptic ephrinB-EphB receptor activation of the Rho-GEF kalirin. Neuron. 2003;37:263–274. [PubMed]
68. Penzes P, Johnson RC, Sattler R, Zhang X, Huganir RL, Kambampati V, Mains RE, Eipper BA. The neuronal Rho-GEF Kalirin-7 interacts with PDZ domain-containing proteins and regulates dendritic morphogenesis. Neuron. 2001;29:229–242. [PubMed]
69. Ran X, Song J. Structural insight into the binding diversity between the Tyr-phosphorylated human ephrinBs and Nck2 SH2 domain. J Biol Chem. 2005;280:19205–19212. [PubMed]
70. Rodenas-Ruano A, Perez-Pinzon MA, Green EJ, Henkemeyer M, Liebl DJ. Distinct roles for ephrinB3 in the formation and function of hippocampal synapses. Dev Biol. 2006;292:34–45. [PubMed]
71. Shamah SM, Lin MZ, Goldberg JL, Estrach S, Sahin M, Hu L, Bazalakova M, Neve RL, Corfas G, Debant A, Greenberg ME. EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell. 2001;105:233–244. [PubMed]
72. Song J, Vranken W, Xu P, Gingras R, Noyce RS, Yu Z, Shen SH, Ni F. Solution structure and backbone dynamics of the functional cytoplasmic subdomain of human ephrin B2, a cell-surface ligand with bidirectional signaling properties. Biochemistry. 2002;41:10942–10949. [PubMed]
73. Stapleton D, Balan I, Pawson T, Sicheri F. The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization. Nat Struct Biol. 1999;6:44–49. [PubMed]
74. Stein E, Savaskan NE, Ninnemann O, Nitsch R, Zhou R, Skutella T. A role for the Eph ligand ephrin-A3 in entorhino-hippocampal axon targeting. J Neurosci. 1999;19:8885–8893. [PubMed]
75. Takasu MA, Dalva MB, Zigmond RE, Greenberg ME. Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors. Science. 2002;295:491–495. [PubMed]
76. Tanaka M, Kamata R, Sakai R. Phosphorylation of ephrin-B1 via the interaction with claudin following cell-cell contact formation. Embo J. 2005;24:3700–3711. [PubMed]
77. Tanaka M, Ohashi R, Nakamura R, Shinmura K, Kamo T, Sakai R, Sugimura H. Tiam1 mediates neurite outgrowth induced by ephrin-B1 and EphA2. Embo J. 2004;23:1075–1088. [PubMed]
78. Thanos CD, Goodwill KE, Bowie JU. Oligomeric structure of the human EphB2 receptor SAM domain. Science. 1999;283:833–836. [PubMed]
79. Tolias KF, Bikoff JB, Burette A, Paradis S, Harrar D, Tavazoie S, Weinberg RJ, Greenberg ME. The Rac1-GEF Tiam1 couples the NMDA receptor to the activity-dependent development of dendritic arbors and spines. Neuron. 2005;45:525–538. [PubMed]
80. Tomita T, Tanaka S, Morohashi Y, Iwatsubo T. Presenilin-dependent intramembrane cleavage of ephrin-B1. Mol Neurodegener. 2006;1:2. [PMC free article] [PubMed]
81. Torres R, Firestein BL, Dong H, Staudinger J, Olson EN, Huganir RL, Bredt DS, Gale NW, Yancopoulos GD. PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands. Neuron. 1998;21:1453–1463. [PubMed]
82. Waites CL, Craig AM, Garner CC. Mechanisms of vertebrate synaptogenesis. Annu Rev Neurosci. 2005;28:251–274. [PubMed]
83. Xu B, Li S, Brown A, Gerlai R, Fahnestock M, Racine RJ. EphA/ephrin-A interactions regulate epileptogenesis and activity-dependent axonal sprouting in adult rats. Mol Cell Neurosci. 2003;24:984–999. [PubMed]
84. Xu Z, Lai KO, Zhou HM, Lin SC, Ip NY. Ephrin-B1 reverse signaling activates JNK through a novel mechanism that is independent of tyrosine phosphorylation. J Biol Chem. 2003;278:24767–24775. [PubMed]
85. Yamaguchi Y, Pasquale EB. Eph receptors in the adult brain. Curr Opin Neurobiol. 2004;14:288–296. [PubMed]
86. Yin Y, Yamashita Y, Noda H, Okafuji T, Go MJ, Tanaka H. EphA receptor tyrosine kinases interact with co-expressed ephrin-A ligands in cis. Neurosci Res. 2004;48:285–296. [PubMed]
87. Yokote H, Fujita K, Jing X, Sawada T, Liang S, Yao L, Yan X, Zhang Y, Schlessinger J, Sakaguchi K. Trans-activation of EphA4 and FGF receptors mediated by direct interactions between their cytoplasmic domains. Proc Natl Acad Sci U S A. 2005;102:18866–18871. [PubMed]
88. Yue Y, Chen ZY, Gale NW, Blair-Flynn J, Hu TJ, Yue X, Cooper M, Crockett DP, Yancopoulos GD, Tessarollo L, Zhou R. Mistargeting hippocampal axons by expression of a truncated Eph receptor. Proc Natl Acad Sci U S A. 2002;99:10777–10782. [PubMed]
89. Yuste R, Bonhoeffer T. Morphological changes in dendritic spines associated with long-term synaptic plasticity. Annu Rev Neurosci. 2001;24:1071–1089. [PubMed]
90. Zhang J, Hughes S. Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system. J Pathol. 2006;208:453–461. [PubMed]
91. Zhang JH, Cerretti DP, Yu T, Flanagan JG, Zhou R. Detection of ligands in regions anatomically connected to neurons expressing the Eph receptor Bsk: potential roles in neuron-target interaction. J Neurosci. 1996;16:7182–7192. [PubMed]